Partner Liane Peterson was quoted in a Bloomberg Law article, “Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry,” about the growth in the number of generic drugmakers seeking to bring competing versions of brand name products to market as quickly as possible.
Peterson said the trend has led to more smaller players jumping in to be first-filers on profitable drugs, which “would suggest the bigger players don’t want to share the market with anyone else.”
People
Related News
February 13, 2026
In the News
Nathan Beaver Shares Insight on FDA Oversight of Pharmaceutical Compounders
Foley & Lardner partner LLP Nathan Beaver shared insight on the U.S. Food and Drug Administration's oversight of pharmaceutical compounders in the Reuters’ article, “U.S. Could Take Action Including Fines Against Hims After Brief Wegovy Copy Launch.”
February 13, 2026
In the News
J.P. Vogel Featured Across Media for Foley Arrival – 'This feels like the ultimate landing point'
Foley & Lardner LLP partner J.P. Vogel attracted widespread media coverage for his recent arrival to the firm’s Dallas office.
February 10, 2026
In the News
Foley's 2026 Data Center Development Report Featured Across Media
Foley & Lardner LLP is featured across media for the firm's 2026 Data Center Development Report exploring the explosive growth within the industry.